According to Inogen's latest financial reports and stock price the company's current Operating Margin is -11.22%. At the end of 2021 the company had an Operating Margin of 2.42%.
Year | Operating Margin | Change |
---|---|---|
2021 | 2.42% | -241.31% |
2020 | -1.71% | -125.52% |
2019 | 6.71% | -40.64% |
2018 | 11.30% | -4.98% |
2017 | 11.89% | 6.11% |
2016 | 11.20% | 20.97% |
2015 | 9.26% | 3.69% |
2014 | 8.93% | 75.12% |
2013 | 5.10% | 325.71% |
2012 | 1.20% | -118.45% |
2011 | -6.49% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
ResMed RMD | 26.84% | -339.22% | ๐บ๐ธ USA |
Masimo MASI | 9.49% | -184.58% | ๐บ๐ธ USA |
Chart Industries GTLS | 8.08% | -172.01% | ๐บ๐ธ USA |
Allied Healthcare Products AHPI | -17.60% | 56.86% | ๐บ๐ธ USA |
Philips PHG | -9.70% | -13.55% | ๐ณ๐ฑ Netherlands |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.